Together, these results indicated a negative correlation between CBX1 expression and the anti‐PD‐1 response and suggested that targeting CBX1 could inhibit IFN‐γ‐STAT1 signaling‐induced PD‐L1 expression, which might further suppress immune evasion in NPC. Here, CBX1 is linked to nasopharyngeal carcinoma.